Login / Signup

Antiviral signaling by a cyclic nucleotide activated CRISPR protease.

Christophe RouillonNiels SchnebergerHaotian ChiKatja BlumenstockStefano Da VelaKatrin AckermannJonas MoeckingMartin F PeterWolfgang BoenigkReinhard SeifertBela Ernest BodeJonathan L Schmid-BurgkDmitri I SvergunMatthias GeyerMalcolm F WhiteGregor Hagelueken
Published in: Nature (2022)
CRISPR defense systems such as the well-known DNA-targeting Cas9 and the RNA-targeting type III systems are widespread in prokaryotes 1,2 . The latter can orchestrate a complex antiviral response that is initiated by the synthesis of cyclic oligoadenylates (cOAs) upon foreign RNA recognition 3-5 . Among a large set of proteins that were linked to type III systems and predicted to bind cOAs 6,7 , a CRISPR associated Lon protease (CalpL) stood out to us. The protein contains a sensor domain of the SAVED (SMODS-associated and fused to various effector domains) family 7 , fused to a Lon protease effector domain. However, the mode of action of this effector was unknown. Here, we report the structure and function of CalpL and show that the soluble protein forms a stable tripartite complex with two further proteins, CalpT and CalpS, that are encoded in the same operon. Upon activation by cA 4 , CalpL oligomerizes and specifically cleaves the MazF-homolog CalpT, releasing the extracytoplasmic function (ECF) sigma factor CalpS from the complex. This provides a direct connection between CRISPR-based foreign nucleic acid detection and transcriptional regulation. Furthermore, the presence of a cA 4 -binding SAVED domain in a CRISPR effector reveals an unexpected link to the cyclic oligonucleotide-based antiphage signaling system (CBASS).
Keyphrases